Evidence map›Paper›PMID 34051438›Full record

ArticleMedical image analysis2021

Deep learning for predicting COVID-19 malignant progression.

Cong Fang, Song Bai, Qianlan Chen, Yu Zhou, Liming Xia, Lixin Qin, Shi Gong, Xudong Xie, Chunhua Zhou, Dandan Tu and 5 more

Abstract readMulticenter Study
In one paragraph

Article in Medical image analysis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review of multimodal machine learning approaches in healthcare.An international journal on information fusion · 2025
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Cong FangSchool of Electronic Information and Communications, Huazhong University of Science and Technology, Wuhan 430074, China.
Song BaiDepartment of Engineering Science, University of Oxford, Parks Road, Oxford OX1 3PJ, United Kingdom.
Qianlan ChenDepartment of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Yu ZhouSchool of Electronic Information and Communications, Huazhong University of Science and Technology, Wuhan 430074, China.
Liming XiaDepartment of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Lixin QinDepartment of Radiology, Wuhan Pulmonary Hospital, Wuhan 430030, China.
Shi GongSchool of Electronic Information and Communications, Huazhong University of Science and Technology, Wuhan 430074, China.
Xudong XieSchool of Electronic Information and Communications, Huazhong University of Science and Technology, Wuhan 430074, China.
Chunhua ZhouDepartment of Radiology, Wuhan Pulmonary Hospital, Wuhan 430030, China.
Dandan TuHUST-HW Joint Innovation Lab, Wuhan 430074, China.
Changzheng ZhangHUST-HW Joint Innovation Lab, Wuhan 430074, China.
Xiaowu LiuHUST-HW Joint Innovation Lab, Wuhan 430074, China.
Weiwei ChenDepartment of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. Electronic address: chenweiwei_tjh@163.com.
Xiang BaiSchool of Electronic Information and Communications, Huazhong University of Science and Technology, Wuhan 430074, China. Electronic address: xbai@hust.edu.cn.
Philip H S TorrDepartment of Engineering Science, University of Oxford, Parks Road, Oxford OX1 3PJ, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As COVID-19 is highly infectious, many patients can simultaneously flood into hospitals for diagnosis and treatment, which has greatly challenged public medical systems. Treatment priority is often determined by the symptom severity based on first assessment. However, clinical observation suggests that some patients with mild symptoms may quickly deteriorate. Hence, it is crucial to identify patient early deterioration to optimize treatment strategy. To this end, we develop an early-warning system with deep learning techniques to predict COVID-19 malignant progression. Our method leverages CT scans and the clinical data of outpatients and achieves an AUC of 0.920 in the single-center study. We also propose a domain adaptation approach to improve the generalization of our model and achieve an average AUC of 0.874 in the multicenter study. Moreover, our model automatically identifies crucial indicators that contribute to the malignant progression, including Troponin, Brain natriuretic peptide, White cell count, Aspartate aminotransferase, Creatinine, and Hypersensitive C-reactive protein.

Indexed as

COVID-19Deep LearningHumansSARS-CoV-2Tomography, X-Ray ComputedCOVID-19Domain adaptationFeature fusionMalignant progression

Identifiers

PMID34051438
PMCPMC8112895

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.